Retinal, ophthalmic, or ocular migraine

Current Neurology and Neuroscience Reports

Volumn 4, Issue 5, 2004, Pages 391-397

  Pradhan, Shilpi ^a   Chung, Sophia M ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ACETYLSALICYLIC ACID; AMITRIPTYLINE; ANTIMIGRAINE AGENT; GABAPENTIN; GLYCERYL TRINITRATE; HEPARIN; IMIPRAMINE; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; PREDNISONE; SEROTONIN UPTAKE INHIBITOR; SULFINPYRAZONE; TOPIRAMATE; VALPROATE SEMISODIUM; VERAPAMIL; WARFARIN;

CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; EYE DISEASE; HUMAN; MEDICAL ASSESSMENT; MIGRAINE; MONOCULAR VISION; NOMENCLATURE; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW; SIDE EFFECT; VISUAL IMPAIRMENT;

EID: 5444272284     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-004-0086-5     Document Type: Review

References (66)

1. Galezowski X: Ophthalmic megrim. Lancet 1882, 1: 176-177.
2. Hupp SL, Kline LB, Corbett JJ: Visual disturbances of migraine. Survey Ophthalmol 1989, 33: 221-236.
3. Kline LB, Kelly CL: Ocular migraine in a patient with cluster headaches. Headache 1980, 20: 253-257.
4. Headache classification committee of the International Headache Society: Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988, 8(Suppl 7): 1-96.
5. Spector RH: Migraine. Survey Ophthalmol 1984, 29: 193-207.
6. O'Conner PS, Tredici TJ: Acephalgic migraine: fifteen years experience. Ophthalmology 1981, 88: 999-1003.
7. O'Sullivan E, Rossor M, Elston JS: Amaurosis fugax in young people. Br J Ophthalmol 1992, 76: 660-662.
8. Tomsak RL, Jergens PB: Benign recurrent transient monocular blindness: a possible variant of acephalgic migraine. Headache 1987, 27: 66-69.
9. Tippin J, Corbett JJ, Kerber RE, et al.: Amaurosis fugax and ocular infarction in adolescents and young adults. Ann Neurol 1989, 26: 69-77.
10. Fujino T, Akiya S, Takagi S, Shiga H: Amaurosis fugax for a long duration. J Clin Neuro-ophthalmol 1983, 3: 9-12.
11. Ewing CC: Recurrent monocular blindness. Lancet 968, 1035-1036.
12. Appleton R, Farrell K, Buncic JR, Hill A: Amaurosis fugax in teenagers: a migraine variant. Am J Dis Child 1988, 142: 331-333.
13. Burger SK, Saul RF, Selhorst JB, Thurston SE: Transient monocular blindness caused by vasospasm. N Engl J Med 1991, 12: 870-873.
14. Newman R, Nancy J, Lessell S, et al.: Bilateral central retinal artery occlusion, disk drusen and migraine. Am J Ophthalmol 1989, 107: 236-240.
15. Biousse V, Newman NJ, Sternberg P Jr: Retinal vein occlusion and transient monocular visual loss associated with hyper-homocystinemia. Am J Ophthalmol 1997, 124: 257-260.
16. Narita AS, Elder JE: Ocular migraine in an eight-year-old girl. Aust NZ J Ophthalmol 1994, 22: 275-277.
17. Pandit JC, Fritsche P: Permanent monocular blindness and ocular migraine. J R Soc Med 1997, 90: 691-692.
18. Bernard GA, Bennett JL: Vasospastic amaurosis fugax. Arch Ophthalmol 1999, 117: 1568.
19. Coppeto JR, Lessell S, Sciarra R, Bear L: Vascular retinopathy in migraine. Neurology 1986, 36: 267-270.
20. Glenn AM, Shaw PJ, Howe JW, Bates D: Complicated migraine resulting in blindness due to bilateral retinal infarction. Br J Ophthalmol 1992, 76: 189-190.
21. Inan LE, Uysal H, Ergün U, et al.: Complicated retinal migraine. Headache 1994, 34: 50-52.
22. Beversdorf D, Stommel E, Allen C, et al.: Recurrent branch retinal infarcts in association with migraine. Headache 1997, 37: 396-399.
23. Victor DI, Welch RB: Bilateral retinal hemorrhages and disk edema in migraine. Am J Ophthalmol 1977, 84: 555-558.
24. Wolter JR, Burchfield WJ: Ocular migraine in a young man resulting in unilateral transient blindness and retinal edema. J Pediatr Ophthalmol 1971, 8: 173-176.
25. Brown GC, Magargal LE, Shields JA, et al.: Retinal arterial occlusion in children and young adults. Am J Ophthalmol 1981, 88: 18-25.
26. Winterkorn JM, Burde RM: Vasospasm - not migraine - in the anterior visual pathway. Ophthalmol Clin North Am 1996, 9: 393-405.
27. Carroll D: Retinal migraine. Headache 1970, 10: 9-13.
28. Corbett JJ: Neuro-ophthalmic complications of migraine and cluster headaches. Neurol Clin 1983, 1: 973-995.
29. Imes RK, Hoyt WF: Exercise-induced transient visual effects in young health adults. J Clin Neuro-ophthalmol 1989, 9: 178-180.
30. Winterkorn JM, Kupersmith MJ, Wirtschafter JD, Forman S: Brief report: treatment of vasospastic amaurosis fugax with calcium-channel blockers. N Engl J Med 1993, 329: 396-398.
31. Williams JK, Baumbach GL, Armstrong ML, Heistad DD: Hypothesis: vasoconstriction contributes to amaurosis fugax. J Cereb Blood Flow Metab 1989, 9: 111-116.
32. Shaw HE, Osher RH, Smith JL: Amaurosis fugax associated with SC hemoglobinopathy and lupus erythematosus. Am J Ophthalmol 1979, 87: 281-285.
33. Gronvall A: On changes in the fundus oculi and persisting injuries to the eye in migraine. Acta Ophthalmol 1938, 16: 602-611.
34. Gorji A: Spreading depression: a review of the clinical relevance. Brain Res Rev 2001, 38: 33-60.
35. Breslau N, Lipton RB, Stewart WF, et al.: Comorbidity of migraine and depression: investigating potential etiology and prognosis. Neurology 2003, 60: 1308-1312.
36. Tzourio C, Tehindrazanarivelo A, Iglesias S, et al.: Case control study of migraine and risk of ischemic stroke in young women. BMJ 1995, 310: 830-833.
37. Buring JE, Hebert P, Romero J, et al.: Migraine and subsequent risk of stroke in the Physicians' Health Study. Arch Neurol 1995, 52: 129-134.
38. Lipton RB, Stewart WF, Diamond S, et al.: Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001, 41: 646-657.
39. Hachinski VC, Porchawka J, Steele JC: Visual symptoms in the migraine syndrome. Neurology 1973, 23: 570-579.
40. Abu-Arefeh I, Russell G: Prevalence of headache and migraine in school children. BMJ 1994, 309: 765-769.
41. Jehn A, Dettwiler BF, Fleischhauer J, et al.: Exercise induced vasospastic amaurosis fugax. Arch Ophthalmol 2002, 120: 220-222.
42. Terwindt GM, Ophoff RA, van Eijk R, et al.: Involvement of the CACNA1A gene containing region on 19p13 in migraine with and without aura. Neurology 2001, 56: 1028-1032.
43. Tzourio C, El Amrani M, Poirier O, et al.: Association between migraine and endothelin type A receptor (ETA-231 A/G) gene polymorphism. Neurology 2001, 56: 1273-1277.
44. Amaurosis Fugax Study Group: Current management of amaurosis fugax. Stroke 1990, 21: 201-208.
45. Burde RM: Amaurosis fugax: an overview. J Clin Neuro-ophthalmol 1989, 9: 185-189.
46. Goodwin JA, Gorelick P, Helgason C: Transient monocular visual loss: amaurosis fugax versus migraine. Neurology 1984, 34: 246.
47. Ross Russell RW, Page NG: Critical perfusion of brain and retina. Brain 1983, 106: 419-434.
48. Fisher CM: Transient monocular blindness associated with hemiplegia. Arch Ophthalmol 1952, 47: 167-203.
49. Winterkorn JM, Teman AJ: Recurrent attacks of amaurosis fugax treated with calcium channel blocker. Ann Neurol 1991, 30: 423-425.
50. Digre KB, Durcan FJ, Branch DW, et al.: Amaurosis fugax associated with antiphopholipid antibodies. Ann Neurol 1989, 25: 228-232.
51. Smith DB: Protein C deficiency: a cause of amaurosis fugax. J Neurol Neurosurg Psychiatry 1987, 50: 361-362.
52. Doyle E, Vote BJ, Casswell AG: Retinal migraine: caught in the act. Br J Ophthalmol 2004, 88: 301-302.
53. Ehinger B: Adrenergic nerves to the eye and to related structures in man and in the cynomolgus monkey (Macaca irus). Invest Ophthal 1966, 5: 42-52.
54. Welch KM: Contemporary concepts of migraine pathogenesis. Neurology 2003, 61(8 Suppl 4): S2-S8.
55. Lauritzen M: Cortical spreading depression as a putative migraine mechanism. Trends Neurosci 1987, 10: 8-13.
56. Sandler M: Migraine: a pulmonary disease. Lancet 1972, 1: 618-619.
57. Wiedemann M, de Lima VM, Hanke W: Effects of antimigraine drugs on retinal spreading depression. Naunyn Schmiedeberg's Arch Pharmacol 1996, 353: 552-556.
58. Couch J, Hassanein R: Platelet aggregability in migraine. Neurology 1977, 27: 843-848.
59. Byrne E: Retinal migraine and the pill. Med J Aust 1979, 2: 659-660.
60. Kudrow L: The relationship of headache frequency to hormone in migraine. Headache 1975, 15: 36-40.
61. Ratinahirana H, Darbois Y, Bousser MG: Migraine and pregnancy: a prospective study in 702 women after delivery. Neurology 1990, 40(Suppl 1): 437.
62. Johannes CB, Linet MS, Stewart WF, et al.: Relationship of headache to phase of the menstrual cycle among young women: a daily diary study. Neurology 1995, 45: 1076-1082.
63. Solomon GD, Steel JG, Spaccavento LJ: Verapamil prophylaxis of migraine: a double-blind, placebo-controlled study. JAMA 1983, 250: 2500-2502.
64. Silberstein SD: Practice parameter: evidence-based guidelines for migraine headache (an evidence based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000, 55: 754-762.
65. Miller FW, Santoro TJ: Nifedipine in the treatment of migraine headache and amaurosis fugax in patients with systemic lupus erythematosis. N Engl J Med 1981, 311: 921.
66. Killer HE, Forrer A, Flammer J: Retinal vasospasm during an attack of migraine. Retina 2003, 23: 253-254.